ANGUS Unveils a New Division
ANGUS reveals ANGUS Life Sciences as a new company division that will serve pharmaceutical, biotechnology, and agriculture markets.
ANGUS Chemical Company, a manufacturer and marketer of nitroalkanes and their derivatives, announced on March 14, 2016 the launch of its new life-sciences division, ANGUS Life Sciences. ANGUS Life Sciences supplies customers in the biotechnology, pharmaceutical, and agriculture markets with buffers, biochemicals, biomolecules, and intermediates.
Based in the US, ANGUS Life Sciences is a fully integrated manufacturer of TRIS AMINO buffers, based on their nitroalkane chemistry. In addition to TRIS AMINO, ANGUS Life Sciences also provides other offerings, including biological buffers, biochemicals, biomolecules, and amino acids.
Source: ANGUS
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Pharmaceutical Tariffs Are Imminent: How Industry is Bracing for Impact
April 16th 2025On April 14, 2025, the Trump Administration launched a national security-driven investigation into pharmaceuticals, a move that will likely result in tariffs being placed on pharmaceutical drugs, ingredients, and other components that are imported from outside of the United States.
